Posted On: 11/09/2016 9:42:33 AM
Post# of 72447
Biotech stocks are surging in pre-open trade on Trump Win. Trump is viewed as potentially less onerous than Clinton on drug pricing.
XBI (NYSE: XBI) is up 5.6%
IBB (NYSE: IBB) is up 6%
Gilead Sciences (NASDAQ: GILD) +3.8%
Celgene (NASDAQ: CELG) +4%
Amgen (NASDAQ: AMGN) +5%
Biogen (NASDAQ: BIIB) +4%
XBI (NYSE: XBI) is up 5.6%
IBB (NYSE: IBB) is up 6%
Gilead Sciences (NASDAQ: GILD) +3.8%
Celgene (NASDAQ: CELG) +4%
Amgen (NASDAQ: AMGN) +5%
Biogen (NASDAQ: BIIB) +4%
(1)
(0)
